Press Release | Thu May 15, 2014 10:00pm EDT

Orteronel Plus Prednisone Improved Progression Free Survival in Men With Chemotherapy-Naïve Metastatic Castration Resistant Prostate Cancer in Phase 3 Study<4502.T>

* Reuters is not responsible for the content in this press release.